Skip to main content
. 2021 Oct 25;11(4):e43. doi: 10.5415/apallergy.2021.11.e43

Table 3. Symptom score changes by condition.

Symptom score by condition Immunotherapy group Drug only group p-value
Bronchial asthma n = 51 n = 17
−3 0 (0) 0 (0)
−2 0 (0) 0 (0)
−1 0 (0) 3 (17.65)
0 1 (1.96) 5 (29.41)
1 8 (15.69) 5 (29.41)
2 42 (82.35) 4 (23.53)
3 0 (0) 0 (0)
Mean±SD 1.88±0.45 0.59±1.06 <0.001
Median (range) 2 (0–2) 1 (−1 to 2)
Allergic rhinitis n = 51 n = 17
−3 0 (0) 0 (0)
−2 0 (0) 1 (5.88)
−1 0 (0) 2 (11.76)
0 11 (21.57) 8 (47.06)
1 20 (39.22) 4 (23.53)
2 20 (39.22) 2 (23.53)
3 0 (0) 0 (0)
Mean±SD 1.18±0.45 0.24±1.06 0.001
Median (range) 2 (0–2) 0 (−2 to 2)
Upper respiratory tract infection n = 51 n = 17
−3 0 (0) 0 (0)
−2 0 (0) 0 (0)
−1 0 (0) 0 (0)
0 2/51 (3.92) 8 (47.06)
1 10 (19.61) 6 (35.29)
2 38 (74.51) 3 (0)
3 1 (1.96) 0 (0)
Mean±SD 1.75±0.56 0.71±0.77 <0.001
Median (range) 2 (0–3) 1 (0–2)

SD, standard deviation.

Wilcoxon rank-sum test comparing change in immunotherapy group to drug only group.

Score: −3, much worse; −2, a good deal worse; −1, slightly worse; 0, more or less the same; +1, slightly better; +2, a good deal better; +3, much better.